Annual Total Long Term Liabilities
$0.00
-$75.84 M-100.00%
June 30, 2024
Summary
- As of February 8, 2025, MEIP annual total long term liabilities is $0.00, with the most recent change of -$75.84 million (-100.00%) on June 30, 2024.
- During the last 3 years, MEIP annual total long term liabilities has fallen by -$104.42 million (-100.00%).
- MEIP annual total long term liabilities is now -100.00% below its all-time high of $118.91 million, reached on June 30, 2020.
Performance
MEIP Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, MEIP quarterly total long term liabilities is $0.00, unchanged on September 30, 2024.
- Over the past year, MEIP quarterly long term liabilities has dropped by -$10.62 million (-100.00%).
- MEIP quarterly long term liabilities is now -100.00% below its all-time high of $118.91 million, reached on June 30, 2020.
Performance
MEIP Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
MEIP Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | -100.0% |
| 3 y3 years | -100.0% | -100.0% |
| 5 y5 years | -100.0% | -100.0% |
MEIP Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
MEI Pharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2024 | - | $10.62 M(-3.6%) |
| Dec 2023 | - | $11.01 M(-2.8%) |
| Sep 2023 | - | $11.33 M(-85.1%) |
| Jun 2023 | $75.84 M(-24.9%) | $75.84 M(-0.5%) |
| Mar 2023 | - | $76.21 M(-0.5%) |
| Dec 2022 | - | $76.57 M(-25.5%) |
| Sep 2022 | - | $102.84 M(+1.8%) |
| Jun 2022 | $100.98 M(-3.3%) | $100.98 M(-1.6%) |
| Mar 2022 | - | $102.67 M(+1.0%) |
| Dec 2021 | - | $101.69 M(-10.9%) |
| Sep 2021 | - | $114.16 M(+9.3%) |
| Jun 2021 | $104.42 M(-12.2%) | $104.42 M(-3.1%) |
| Mar 2021 | - | $107.78 M(+15.4%) |
| Dec 2020 | - | $93.37 M(-6.8%) |
| Sep 2020 | - | $100.19 M(-15.7%) |
| Jun 2020 | $118.91 M(+482.0%) | $118.91 M(+901.9%) |
| Mar 2020 | - | $11.87 M(-40.3%) |
| Dec 2019 | - | $19.89 M(+71.8%) |
| Sep 2019 | - | $11.57 M(-43.3%) |
| Jun 2019 | $20.43 M(-55.9%) | $20.43 M(-43.5%) |
| Mar 2019 | - | $36.19 M(+13.3%) |
| Dec 2018 | - | $31.93 M(-36.4%) |
| Sep 2018 | - | $50.21 M(+8.4%) |
| Jun 2018 | $46.31 M(>+9900.0%) | $46.31 M(>+9900.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | - | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | $0.00 | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | - | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $1.49 M(>+9900.0%) |
| Jun 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | - | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | - | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | - | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | - | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | - | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | - | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | - | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Jun 2003 | $0.00 | $0.00 |
FAQ
- What is MEI Pharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for MEI Pharma?
- What is MEI Pharma annual total long term liabilities year-on-year change?
- What is MEI Pharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for MEI Pharma?
- What is MEI Pharma quarterly long term liabilities year-on-year change?
What is MEI Pharma annual total long term liabilities?
The current annual total long term liabilities of MEIP is $0.00
What is the all time high annual total long term liabilities for MEI Pharma?
MEI Pharma all-time high annual total long term liabilities is $118.91 M
What is MEI Pharma annual total long term liabilities year-on-year change?
Over the past year, MEIP annual total long term liabilities has changed by -$75.84 M (-100.00%)
What is MEI Pharma quarterly total long term liabilities?
The current quarterly long term liabilities of MEIP is $0.00
What is the all time high quarterly long term liabilities for MEI Pharma?
MEI Pharma all-time high quarterly total long term liabilities is $118.91 M
What is MEI Pharma quarterly long term liabilities year-on-year change?
Over the past year, MEIP quarterly total long term liabilities has changed by -$10.62 M (-100.00%)